9-dihydro-13-acetylbaccatin III
CAS No. 142203-65-4
9-dihydro-13-acetylbaccatin III ( 13-Acetyl-9-dihydrobaccatin III;9-DHAB III )
Catalog No. M19922 CAS No. 142203-65-4
9-Dihydro-13-acetylbaccatin III is an apoptosis inducer. It shows cytotoxicity against the MCF7 cell line and drug-resistant cell line MCF7-ADR.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 53 | In Stock |
|
10MG | 87 | In Stock |
|
25MG | 176 | In Stock |
|
50MG | 260 | In Stock |
|
100MG | 386 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Name9-dihydro-13-acetylbaccatin III
-
NoteResearch use only not for human use.
-
Brief Description9-Dihydro-13-acetylbaccatin III is an apoptosis inducer. It shows cytotoxicity against the MCF7 cell line and drug-resistant cell line MCF7-ADR.
-
Description9-Dihydro-13-acetylbaccatin III is an apoptosis inducer. It shows cytotoxicity against the MCF7 cell line and drug-resistant cell line MCF7-ADR.
-
Synonyms13-Acetyl-9-dihydrobaccatin III;9-DHAB III
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number142203-65-4
-
Formula Weight630.68
-
Molecular FormulaC33H42O12
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM;Ethanol: Soluble
-
SMILESCC(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)[C@@H](O)[C@H](OC(C)=O)C(=C1C)C2(C)C)OC(C)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nikolakakis A et al. Semi-synthesis of an O-glycosylated docetaxel analogue. Bioorg Med Chem. 2003 Apr 3;11(7):1551-6.
molnova catalog
related products
-
Hinokitiol
Hinokitiol (4-Isopropyltropolone;β-Thujaplicin) is a tropolone-related natural compound that can induces apoptosis and cell cycle arrest.
-
NHWD-870
NHWD-870 is an effective and selective inhibitor of BET family bromodomain only binding to BRD2, BRD3, BRD4 (IC50 = 2.7 nM), and BRDT.
-
TJ191
TJ191 is a selective anti-cancer agent, targeting low TβRIII-expressing malignant T-cell leukemia/lymphoma cells.